
Cellectis
Develops 'off-the-shelf' CAR T-cell cancer immunotherapies using TALEN® gene-editing.
ALCLS | PA
Overview
Corporate Details
- ISIN(s):
- FR0010425595 (+2 more)
- LEI:
- 5493000KKX5VQ37Q2W83
- Country:
- France
- Address:
- 8 RUE DE LA CROIX JARRY, 75013 PARIS
- Website:
- https://cellectis.com/en
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Cellectis is a clinical-stage biopharmaceutical company specializing in the development of cancer immunotherapies. The company leverages its proprietary TALEN® gene-editing technology to engineer Chimeric Antigen Receptor (CAR) T-cells from healthy donors. This creates allogeneic, or "off-the-shelf," product candidates designed for broad patient accessibility, providing a scalable alternative to individualized autologous therapies. Cellectis' platform aims to solve key challenges in allogeneic cell therapy, such as Graft-versus-Host Disease (GvHD) and host rejection, while integrating safety features. The company possesses a strong intellectual property portfolio and collaborates with global strategic partners to advance its therapeutic pipeline.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
Date | Filing | Language | Size | Actions | |
---|---|---|---|---|---|
2025-06-05 22:30 |
Declaration of Voting Results & Voting Rights Announcements
Information mensuelle relative au nombre total des droits de vote et d’actions …
|
French | 83.2 KB | ||
2025-06-05 22:30 |
Declaration of Voting Results & Voting Rights Announcements
Monthly information on share capital and company voting rights
|
English | 84.7 KB | ||
2025-05-21 22:30 |
Pre-Annual General Meeting Information
L’Assemblée Générale Mixte de Cellectis se tiendra le 26 juin 2025
|
French | 44.7 KB | ||
2025-05-21 22:30 |
Pre-Annual General Meeting Information
Cellectis’ Annual Shareholders General Meeting to be Held on June 26, 2025
|
English | 84.0 KB | ||
2025-05-12 22:30 |
Earnings Release
Cellectis publie ses résultats financiers du premier trimestre 2025
|
French | 232.9 KB | ||
2025-05-12 22:30 |
Earnings Release
Cellectis Reports Financial Results for the First Quarter 2025
|
English | 216.6 KB | ||
2025-05-07 22:30 |
Declaration of Voting Results & Voting Rights Announcements
Information mensuelle relative au nombre total des droits de vote et d’actions …
|
French | 83.3 KB | ||
2025-05-07 22:30 |
Declaration of Voting Results & Voting Rights Announcements
Monthly information on share capital and company voting rights
|
English | 84.8 KB | ||
2025-05-06 22:30 |
Report Publication Announcement
Cellectis publiera ses résultats financiers du premier trimestre le 12 mai 2025
|
French | 67.7 KB | ||
2025-05-06 22:30 |
Report Publication Announcement
Cellectis to Report First Quarter Financial Results on May 12, 2025
|
English | 77.3 KB | ||
2025-04-28 22:39 |
Regulatory News Service
Cellectis présente une approche non virale d’édition du génome et des innovatio…
|
French | 190.3 KB | ||
2025-04-28 22:30 |
Regulatory News Service
Cellectis Presents Non-Viral Gene Editing and Base Editing Innovation at the AS…
|
English | 75.1 KB | ||
2025-04-07 22:30 |
Declaration of Voting Results & Voting Rights Announcements
Information mensuelle relative au nombre total des droits de vote et d’actions …
|
French | 122.2 KB | ||
2025-04-07 22:30 |
Declaration of Voting Results & Voting Rights Announcements
Monthly information on share capital and company voting rights
|
English | 91.5 KB | ||
2025-03-13 23:46 |
Annual Report
Cellectis publie ses résultats financiers du quatrième trimestre 2024 et de l’e…
|
French | 250.5 KB |
Automate Your Workflow. Get a real-time feed of all Cellectis filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Cellectis via our API.
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |